Hydrokortison PharmSwed
Hydrocortisone 1% Cream – Mild Topical Corticosteroid for Skin Inflammation
Quick Facts About Hydrokortison PharmSwed
Key Takeaways About Hydrokortison PharmSwed
- Mildest available corticosteroid: Hydrocortisone 1% is the weakest topical steroid (Group I), making it suitable for sensitive areas and short-term OTC use
- Do not use longer than 7 days without medical advice: Prolonged unsupervised use can cause skin thinning, stretch marks and other adverse effects
- Apply a thin layer only to affected skin: Use the fingertip unit (FTU) method to measure the correct amount and avoid over-application
- Not for infected or broken skin: Do not apply to open wounds, infected areas, acne, rosacea or fungal infections without medical guidance
- Safe in pregnancy when used sparingly: Considered low risk when applied in small amounts for short periods, but always consult a healthcare provider
What Is Hydrokortison PharmSwed and What Is It Used For?
Hydrokortison PharmSwed is a mild topical corticosteroid cream containing 1% hydrocortisone. It is used to treat mild to moderate skin inflammation including eczema, contact dermatitis, insect bite reactions and minor skin irritations. It works by reducing redness, swelling, itching and discomfort at the application site.
Hydrocortisone belongs to a group of medicines known as corticosteroids, sometimes referred to as “steroids” (not to be confused with anabolic steroids used in sports). When applied to the skin, hydrocortisone reduces the body’s inflammatory response by suppressing the release of chemical mediators that cause redness, swelling, heat and itching. At a concentration of 1%, it is classified as a mild (Group I) topical corticosteroid, which is the lowest potency category available.
This classification means hydrocortisone 1% cream has a favourable safety profile compared to stronger topical steroids and is widely approved for over-the-counter sale in most countries worldwide. It has been used clinically for over six decades, with an extensive evidence base supporting its efficacy and safety for a wide range of mild inflammatory skin conditions. The World Health Organization includes hydrocortisone on its Model List of Essential Medicines, recognising its importance in global healthcare.
Common Indications
Hydrokortison PharmSwed cream is commonly used for the following conditions:
- Mild to moderate eczema (atopic dermatitis): Reduces flare-up symptoms including redness, dryness, scaling and intense itching. Particularly effective for short-term management of acute flares in combination with emollient therapy.
- Contact dermatitis: Relieves skin reactions caused by exposure to irritants (such as detergents and chemicals) or allergens (such as nickel, latex or certain plants like poison ivy).
- Insect bite reactions: Reduces swelling, redness and itching from bites and stings from mosquitoes, midges, fleas, bedbugs and other insects.
- Mild seborrhoeic dermatitis: Can help manage flaky, itchy skin on the scalp, face and body folds.
- Nappy rash (mild cases): May be used under medical guidance for short periods in infants with inflammatory nappy rash that has not responded to barrier creams alone.
- Heat rash (miliaria): Helps reduce inflammation and discomfort from heat-related skin eruptions.
- Mild sunburn: May provide symptomatic relief from mild sunburn when applied after initial cooling.
How Does Hydrocortisone Work?
When you apply hydrocortisone cream to inflamed skin, the active ingredient penetrates the outer layers of the epidermis and binds to glucocorticoid receptors inside skin cells. This binding triggers a cascade of anti-inflammatory effects: it inhibits the production of prostaglandins, leukotrienes and cytokines – chemical messengers responsible for the redness, swelling and itching you experience during inflammation. Additionally, hydrocortisone reduces the dilation of blood vessels in the skin (vasoconstriction), which decreases redness and oedema.
The onset of action is relatively quick for a topical corticosteroid. Most patients notice a reduction in itching within 1–2 hours of application, with visible improvement in redness and swelling typically becoming apparent within 24–48 hours of regular use. The anti-inflammatory effect builds over several days of consistent application, which is why it is important to continue the full recommended treatment course even if symptoms improve early.
Topical corticosteroids are classified into potency groups. Hydrocortisone 1% sits in Group I (mild) – the weakest category. This means it is significantly less potent than commonly prescribed steroids like betamethasone (Group III–IV) or clobetasol (Group IV – superpotent). The low potency of hydrocortisone 1% is precisely what makes it appropriate for OTC use and for application to sensitive areas where stronger steroids would be inadvisable.
What Should You Know Before Using Hydrokortison PharmSwed?
Before using Hydrokortison PharmSwed, ensure the affected area is not infected, broken or an open wound. Do not use on acne, rosacea, perioral dermatitis or fungal infections. Consult a healthcare provider before use if you are pregnant, breastfeeding, or treating a child under 10 years of age.
Although hydrocortisone 1% cream is a mild corticosteroid available without prescription, it is still an active medication that requires careful and appropriate use. Understanding when it should and should not be used is essential for safe and effective treatment. Inappropriate use – particularly on the wrong type of skin condition or for too long – can worsen symptoms or cause new problems.
Contraindications
Do not use Hydrokortison PharmSwed cream in the following situations:
- Bacterial skin infections: Including impetigo, cellulitis and infected wounds. Corticosteroids suppress local immune responses and can allow bacterial infections to spread and worsen. If you suspect a skin infection (increasing redness, warmth, pus, swelling), see a healthcare provider instead.
- Viral skin infections: Including herpes simplex (cold sores), chickenpox (varicella), shingles (herpes zoster) and viral warts. Applying corticosteroids to viral lesions can cause them to spread and delay healing.
- Fungal skin infections: Including athlete’s foot (tinea pedis), ringworm (tinea corporis) and yeast infections (candidiasis). While hydrocortisone may temporarily reduce itching, it can mask the infection and allow it to progress.
- Acne vulgaris: Topical corticosteroids can worsen acne by promoting comedone formation and may cause steroid acne with prolonged use.
- Rosacea and perioral dermatitis: These conditions are notably worsened by topical corticosteroids, even mild ones. Initial improvement may be followed by a severe rebound flare.
- Open wounds or broken skin: Do not apply to cuts, abrasions, ulcers or any area where the skin barrier is significantly compromised, as this increases systemic absorption and infection risk.
- Hypersensitivity: Do not use if you have a known allergy to hydrocortisone or any of the excipients in the cream formulation.
Warnings and Precautions
Exercise caution and consider seeking medical advice in these situations:
- Facial skin: The skin on the face is thinner and more permeable than elsewhere on the body. Use on the face should be limited to 5–7 days maximum. Prolonged facial application can cause perioral dermatitis, skin thinning, telangiectasia (visible small blood vessels) and steroid rosacea.
- Skin folds (intertriginous areas): Areas such as the groin, armpits and under the breasts naturally create an occlusive environment that increases absorption. Use with extra caution in these areas.
- Large areas of skin: Applying to extensive body surface areas increases the total amount of hydrocortisone absorbed systemically. Keep application to the smallest effective area.
- Prolonged use: Continuous use beyond 7 days without medical supervision is not recommended for OTC use. Chronic application can lead to skin atrophy (thinning), striae (stretch marks), telangiectasia and purpura (easy bruising).
- Occlusive dressings: Covering the treated area with airtight dressings, bandages or nappies significantly increases absorption and the risk of systemic effects. Do not use under occlusion unless directed by a physician.
- Diabetes: Patients with diabetes should be aware that topical corticosteroids, particularly when applied to large areas or under occlusion, may affect blood glucose control, though this is rare with hydrocortisone 1%.
Pregnancy and Breastfeeding
Hydrocortisone 1% cream is generally considered compatible with pregnancy when used in small amounts for short durations. It is the mildest topical corticosteroid, and systemic absorption from appropriate topical use is minimal. Large epidemiological studies have not demonstrated an increased risk of birth defects with topical hydrocortisone use during pregnancy.
However, as a general precaution, pregnant women should:
- Use the smallest amount necessary for the shortest duration
- Avoid application to large areas of skin
- Not apply under occlusive dressings
- Consult their healthcare provider or midwife before starting use
During breastfeeding, hydrocortisone 1% cream can be used on most body areas. However, it should not be applied directly to the nipples or areola immediately before breastfeeding, as the infant could ingest the cream. If application to the breast area is necessary, wash the area thoroughly before nursing. The European Medicines Agency (EMA) and most national formularies consider topical hydrocortisone compatible with breastfeeding when used appropriately.
Children’s skin is proportionally thinner than adult skin and has a larger surface area relative to body weight, meaning they absorb more topical medication per kilogram. For children under 10 years, consult a healthcare provider before use. When prescribed for children, use the smallest effective amount for the shortest time. Never apply under nappies (which act as occlusive dressings) without medical direction, and monitor for local side effects such as skin thinning.
How Does Hydrokortison PharmSwed Interact with Other Drugs?
Hydrocortisone 1% cream has few significant drug interactions because of its minimal systemic absorption. The most important interactions are with other topical products applied to the same area. Avoid combining with other topical corticosteroids, retinoids or certain antifungals without medical advice.
Because topical hydrocortisone 1% is absorbed into the bloodstream in only very small amounts when used correctly, clinically significant systemic drug interactions are extremely rare. The interactions that do matter are primarily local – relating to other products applied to the same area of skin. Understanding these interactions helps ensure both safety and optimal therapeutic outcomes.
| Interacting Substance | Type | Effect | Recommendation |
|---|---|---|---|
| Other topical corticosteroids | Major | Additive corticosteroid effect increases risk of skin atrophy and systemic absorption | Do not layer multiple corticosteroid products on the same area |
| Topical retinoids (tretinoin, adapalene) | Moderate | Retinoids thin the stratum corneum, increasing hydrocortisone penetration and potential for irritation | Use at different times of day or on alternate days; consult a dermatologist |
| Topical calcineurin inhibitors (tacrolimus, pimecrolimus) | Minor | Combined immunosuppressive effect on local skin; theoretical increased infection risk | Generally not applied simultaneously; use sequentially under dermatologist guidance |
| Topical antifungals (clotrimazole, miconazole) | Minor | Combination products exist (e.g., hydrocortisone + clotrimazole); hydrocortisone may reduce inflammation but mask fungal progression | Use combination only when both anti-inflammatory and antifungal action are needed; follow medical advice |
| Topical antibiotics (fusidic acid, mupirocin) | Minor | May be combined therapeutically; hydrocortisone can suppress signs of ongoing infection | Use combination products only as directed by a healthcare provider; monitor for infection resolution |
Major Interactions
The most clinically significant interaction is with other topical corticosteroids. Layering multiple corticosteroid-containing products on the same area of skin (for example, applying hydrocortisone cream and then a betamethasone cream over the same area) produces an additive effect that significantly increases the risk of local adverse effects such as skin atrophy, striae and telangiectasia. It also increases total systemic absorption, which could potentially affect the hypothalamic-pituitary-adrenal (HPA) axis with prolonged use.
Patients should also be aware that some over-the-counter products – particularly anti-itch creams, haemorrhoid preparations and some eczema moisturisers – may contain hydrocortisone or other corticosteroids. Using these alongside Hydrokortison PharmSwed constitutes inadvertent double-dosing and should be avoided.
Minor Interactions
When using emollients (moisturisers) alongside hydrocortisone cream – which is actually recommended for optimal eczema management – the order and timing of application matters. Apply the emollient first, wait 15–30 minutes for it to absorb, and then apply the hydrocortisone cream. This allows each product to work effectively without diluting the other or altering its absorption characteristics. Some dermatologists recommend the opposite order; follow your healthcare provider’s specific advice if given.
Cosmetics, sunscreens and other skincare products applied to the same area as hydrocortisone are unlikely to cause clinically significant interactions, but they may affect the cream’s absorption or efficacy. As a general rule, apply the hydrocortisone cream first, allow it to absorb fully, and then apply other products.
What Is the Correct Dosage of Hydrokortison PharmSwed?
Apply a thin layer of Hydrokortison PharmSwed 1% cream to the affected area 1–2 times daily. Use the fingertip unit (FTU) method to measure the correct amount. Do not use for more than 7 consecutive days without medical advice. For children under 10, consult a healthcare provider before use.
Correct dosing of topical corticosteroids is crucial for achieving the desired therapeutic effect while minimising the risk of side effects. Unlike oral medications where the dose is measured in milligrams or millilitres, topical corticosteroid dosing relies on the fingertip unit (FTU) system. One FTU is the amount of cream squeezed from a standard tube along an adult’s fingertip, from the tip to the first crease – approximately 0.5 grams. One FTU covers an area of skin approximately equal to two adult flat palms (including fingers).
Adults
Standard Adult Dosing
- Frequency: Apply 1–2 times daily (morning and/or evening)
- Amount: A thin layer to the affected area only, using the FTU system as a guide
- Duration (OTC): Maximum 7 consecutive days without medical advice
- Duration (prescribed): As directed by your healthcare provider; typically in intermittent courses with treatment-free intervals
| Body Area | FTUs Needed | Approximate Amount |
|---|---|---|
| Hand (one side) | 0.5 FTU | ~0.25 g |
| Arm (one) | 3 FTU | ~1.5 g |
| Leg (one) | 6 FTU | ~3 g |
| Foot (one) | 2 FTU | ~1 g |
| Face and neck | 2.5 FTU | ~1.25 g |
| Trunk (front) | 7 FTU | ~3.5 g |
| Trunk (back) | 7 FTU | ~3.5 g |
Children
Paediatric Dosing Guidelines
- Under 10 years: Consult a healthcare provider before use. When prescribed, use the smallest amount for the shortest duration.
- 10 years and older: May use OTC as for adults, applying a thin layer 1–2 times daily for up to 7 days.
- Infants: Only use under direct medical supervision. Do not apply under nappies (which act as occlusive dressings).
Children require proportionally fewer FTUs than adults due to their smaller body surface area. As a general guide, children aged 1–5 years need approximately one-third to one-half of the adult FTU amount for the same body region.
Elderly
Elderly patients can use hydrocortisone 1% cream at the same dosage as younger adults. However, ageing skin is naturally thinner and more fragile, which means it is more susceptible to corticosteroid-related side effects such as skin thinning, bruising and poor wound healing. Elderly patients should pay particular attention to the duration of use and monitor the treated skin for signs of atrophy. If treatment is needed for longer than 7 days, medical supervision is advisable.
Missed Dose
If you forget to apply your hydrocortisone cream at the scheduled time, apply it as soon as you remember, unless it is almost time for the next application. In that case, skip the missed application and continue with your regular schedule. Do not apply a double amount to compensate for a missed application. Missing a single application is unlikely to significantly affect your treatment outcome.
Overdose
Acute overdose from topical hydrocortisone 1% cream is extremely unlikely. Even if a larger-than-recommended amount is applied, the skin acts as a natural barrier limiting absorption. However, chronic overuse (applying too much for too long, or applying to very large areas of the body) can lead to signs of systemic corticosteroid excess, although this is rare with hydrocortisone 1% and more commonly associated with potent topical steroids.
If accidental ingestion occurs (for example, if a child swallows the cream), it is generally not dangerous. The amount of hydrocortisone in the cream is small, and a single accidental ingestion is unlikely to cause harm. However, contact a healthcare provider or poison control centre for advice, particularly if a large amount has been swallowed.
If you notice skin becoming unusually thin, developing stretch marks, visible blood vessels, persistent redness that worsens rather than improves, or increased skin fragility and bruising, stop using the cream and consult a healthcare provider. These signs indicate that the corticosteroid has been used for too long or in too great a quantity.
What Are the Side Effects of Hydrokortison PharmSwed?
Hydrocortisone 1% cream is generally well tolerated. Common side effects include mild burning or stinging on application and temporary skin dryness. Uncommon effects include skin thinning and stretch marks with prolonged use. Serious systemic side effects are very rare at this low potency.
As one of the mildest topical corticosteroids available, hydrocortisone 1% cream has an excellent safety profile when used as directed. The vast majority of patients experience no side effects at all. When side effects do occur, they are almost always local (at the site of application) and resolve upon discontinuation. The risk of side effects increases with prolonged use, application to large areas, use on thin skin (face, skin folds), and use under occlusive dressings.
The following side effects have been reported with topical hydrocortisone. The frequency categories follow the standard pharmacovigilance classification used by regulatory agencies including the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA):
Common (affects 1–10 in 100 users)
- Mild burning or stinging sensation on application (usually transient, lasting a few minutes)
- Temporary skin dryness or flaking at the application site
- Mild itching (pruritus) at the application site, particularly in the first few days of use
Uncommon (affects 1–10 in 1,000 users)
- Skin thinning (atrophy) with prolonged use beyond recommended duration
- Stretch marks (striae) particularly in skin folds or areas of natural flexion
- Telangiectasia (visible small blood vessels) especially on facial skin
- Contact dermatitis (allergic reaction to the cream itself or its excipients)
- Folliculitis (inflammation of hair follicles) at the application site
Rare (affects fewer than 1 in 1,000 users)
- Hypopigmentation (lightening of skin colour at the application site)
- Hypertrichosis (increased hair growth at the application site)
- Perioral dermatitis (especially with prolonged facial application)
- Secondary skin infection (due to local immunosuppression masking infection signs)
- Systemic effects (HPA axis suppression) – extremely rare with hydrocortisone 1% and only with extensive, prolonged misuse
It is important to distinguish between expected pharmacological effects and true adverse reactions. A mild burning or stinging on first application is common and typically diminishes with continued use – this is a normal response and not a reason to stop treatment unless it is severe or persistent.
If you experience worsening of your original symptoms, spreading redness, increasing pain, or signs of infection (warmth, swelling, pus), stop using the cream and seek medical advice promptly. These may indicate that the underlying condition requires a different treatment approach or that a secondary infection has developed.
Contact your healthcare provider if you notice: visible skin thinning or a “tissue paper” quality to the skin; stretch marks appearing; persistent redness that does not resolve; signs of skin infection; any allergic reaction to the cream (widespread rash, hives, swelling). For severe allergic reactions including breathing difficulty, seek emergency medical help immediately.
How Should You Store Hydrokortison PharmSwed?
Store Hydrokortison PharmSwed cream at room temperature (below 25°C / 77°F), away from direct sunlight and heat. Keep the tube tightly closed when not in use. Do not freeze. Keep out of the sight and reach of children. Do not use after the expiry date printed on the tube and carton.
Proper storage of Hydrokortison PharmSwed cream is important to maintain its efficacy and safety throughout the product’s shelf life. Like most topical medications, the cream’s active ingredient and formulation can degrade when exposed to unfavourable environmental conditions, potentially reducing its effectiveness or altering its properties.
Storage Conditions
- Temperature: Store at room temperature, ideally between 15°C and 25°C (59°F to 77°F). Avoid prolonged exposure to temperatures above 30°C (86°F), such as in a car during summer.
- Light: Keep the tube in its original carton to protect from light when not in use. Ultraviolet light can accelerate degradation of the active ingredient.
- Moisture: Store in a dry place. Avoid keeping the cream in the bathroom where humidity levels fluctuate significantly.
- Freezing: Do not freeze the cream. Freezing can cause the emulsion to separate, rendering the product ineffective and potentially irritating.
- Tube closure: Always replace the cap tightly after each use to prevent contamination and drying of the cream at the nozzle.
Shelf Life and Disposal
Check the expiry date printed on the tube and outer carton before each use. Do not use Hydrokortison PharmSwed after the expiry date (marked as “EXP” on the packaging). Most hydrocortisone cream tubes have a shelf life of 2–3 years from the date of manufacture when stored correctly and unopened.
Once opened, the product should typically be used within 6–12 months (check the period-after-opening symbol on the tube – an open jar icon with a number followed by “M”, indicating months). After this period, the sterility and efficacy of the cream cannot be guaranteed, even if it appears normal.
Dispose of expired or unwanted cream responsibly. Do not flush medicines down the toilet or drain unless specifically instructed. Return unused medicines to a pharmacy for safe disposal through a medicine take-back programme. This protects the environment and prevents accidental exposure.
What Does Hydrokortison PharmSwed Contain?
Hydrokortison PharmSwed cream contains hydrocortisone 1% (10 mg per gram) as the active ingredient. The cream base contains excipients including emulsifying agents, preservatives and water to form a stable, spreadable formulation suitable for topical application.
Active Ingredient
Each gram of Hydrokortison PharmSwed cream contains 10 mg of hydrocortisone (equivalent to 1% w/w concentration). Hydrocortisone is a synthetic form of cortisol, the body’s naturally produced glucocorticoid hormone. In its topical form, it exerts local anti-inflammatory, antipruritic (anti-itch) and vasoconstrictive effects when applied to the skin.
Excipients (Inactive Ingredients)
The cream formulation typically contains a combination of the following inactive ingredients, which serve various pharmaceutical functions:
- Cetostearyl alcohol: An emulsifying and stabilising agent that helps maintain the cream’s consistency and texture. Note: may cause local skin reactions (such as contact dermatitis) in sensitive individuals.
- Liquid paraffin: An emollient that helps the cream spread smoothly and provides a mild moisturising effect.
- White soft paraffin: An occlusive moisturiser that helps retain moisture in the skin and contributes to the cream’s texture.
- Macrogol cetostearyl ether: An emulsifying agent that helps the oil and water phases of the cream remain mixed.
- Chlorocresol or similar preservative: Prevents microbial contamination of the cream. May rarely cause sensitisation in some individuals.
- Citric acid monohydrate: A pH adjuster that helps maintain the cream at an optimal pH for skin compatibility and stability.
- Sodium citrate: A buffering agent working alongside citric acid to stabilise pH.
- Purified water: The vehicle for the aqueous phase of the cream formulation.
If you have known sensitivities to any of the excipients listed above – particularly cetostearyl alcohol or chlorocresol – consult your pharmacist or healthcare provider before use. These ingredients can occasionally cause local contact reactions in sensitised individuals. If you experience increased irritation, redness or rash after application that was not present before, the excipients rather than the active ingredient may be responsible.
Frequently Asked Questions About Hydrokortison PharmSwed
Yes, hydrocortisone 1% cream can be used on the face, but only for short periods of up to 5–7 days. Facial skin is thinner and more sensitive than skin elsewhere on the body, making it more susceptible to side effects such as skin thinning, telangiectasia (visible small blood vessels) and perioral dermatitis. Do not apply near the eyes unless specifically directed by a doctor. If your facial skin condition does not improve within a week, consult a healthcare provider for alternative treatment options.
For OTC (over-the-counter) use, hydrocortisone 1% cream should not be used for longer than 7 consecutive days without consulting a healthcare provider. If your symptoms have not improved within this timeframe, or if they worsen, seek medical advice. A doctor may prescribe continued intermittent use with treatment-free intervals for chronic conditions like eczema, but this should always be under medical supervision with regular skin monitoring.
Hydrocortisone 1% cream is generally considered safe during pregnancy when used in small amounts for short periods. It is the mildest topical corticosteroid and has minimal systemic absorption when applied to small areas of intact skin. Large-scale studies have not shown an increased risk of birth defects. However, as a precaution, avoid applying to large areas, avoid using under occlusive dressings, and consult your healthcare provider or midwife before starting treatment.
Children aged 10 and over can use hydrocortisone 1% cream as directed for OTC use (thin layer, 1–2 times daily, maximum 7 days). For children under 10, consult a healthcare provider before use. Children’s skin is thinner and absorbs proportionally more medication, increasing the risk of side effects. Never apply under nappies or airtight dressings in children unless directed by a doctor, and always use the smallest effective amount.
Hydrocortisone cream (like Hydrokortison PharmSwed) is a water-based emulsion that is light, non-greasy and suitable for moist or weeping skin conditions and skin fold areas. Ointments are oil-based, more occlusive and better suited for dry, thickened or scaly skin. Creams absorb more quickly and are generally more cosmetically acceptable for daytime use, while ointments provide longer-lasting moisturisation and slightly enhanced drug delivery due to their occlusive nature.
Yes, and it is actually recommended, especially for eczema management. Apply your emollient (moisturiser) first to the entire area, wait approximately 15–30 minutes for it to absorb, and then apply the hydrocortisone cream to the affected areas only. This approach keeps the skin well hydrated, supports the skin barrier function, and can reduce the amount of corticosteroid needed over time. Regular emollient use between corticosteroid courses helps maintain skin health and may extend the time between flares.
References and Sources
This article is based on the following peer-reviewed sources and international medical guidelines:
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List (2023). Geneva: WHO; 2023. Hydrocortisone listed as an essential topical anti-inflammatory medicine.
- European Medicines Agency (EMA). Summary of Product Characteristics: Hydrocortisone Cream 1%. EMA assessment of topical hydrocortisone safety and efficacy data.
- British National Formulary (BNF). Topical Corticosteroids: Hydrocortisone. National Institute for Health and Care Excellence (NICE); 2024. Classification, dosing, and safety guidance.
- U.S. Food and Drug Administration (FDA). OTC Monograph for Topical Corticosteroids. FDA guidance on over-the-counter hydrocortisone products.
- Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1-15. doi:10.1016/j.jaad.2005.01.010. Comprehensive review of topical corticosteroid adverse effects.
- Chi CC, Wang SH, Wojnarowska F, et al. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2015;(10):CD007346. Systematic review of topical corticosteroid safety during pregnancy.
- National Eczema Society. Topical Steroids Factsheet. Evidence-based patient information on the safe use of topical corticosteroids.
- Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol. 2014;71(1):116-132. American Academy of Dermatology guidelines including topical corticosteroid use.
- Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657-682. European guidelines on topical corticosteroid therapy in eczema.
- Long CC, Finlay AY. The finger-tip unit – a new practical measure. Clin Exp Dermatol. 1991;16(6):444-447. Original description of the fingertip unit dosing system for topical corticosteroids.
About Our Medical Editorial Team
This article has been written and medically reviewed by the iMedic Medical Editorial Team, which includes board-certified physicians specialising in dermatology, clinical pharmacology and evidence-based medicine. Our team follows the GRADE evidence framework and adheres to the editorial principles outlined in our editorial standards.
Written by qualified medical writers with clinical backgrounds, ensuring accuracy and readability. All medical claims are referenced to peer-reviewed sources.
Reviewed by the iMedic Medical Review Board, an independent panel of specialist physicians who verify clinical accuracy and adherence to international guidelines.
Evidence Level 1A: Based on systematic reviews and meta-analyses of randomised controlled trials. All sources are peer-reviewed and internationally recognised.
No pharmaceutical company funding or advertising. All content is editorially independent with no commercial influence on recommendations.